Dr. Zauderer on the Importance of Optimizing Care in Mesothelioma

Video

Marjorie G. Zauderer, MD, discusses the importance of optimizing care for patients with mesothelioma.

Marjorie G. Zauderer, MD, medical oncologist, co-director, MSK Mesothelioma Program, Memorial Sloan Kettering Cancer Center, discusses the importance of optimizing care for patients with mesothelioma.

The field of mesothelioma is beginning to extrapolate data from other cancers to inform treatment strategies in mesothelioma, Zauderer says. Additionally, mesothelioma is being divided into unique disease subtypes based on biologic factors.

However, despite these efforts, patients with mesothelioma are not receiving enough, if any, care for their disease, Zauderer explains. Although treatment-free intervals may be optimal in some cases, it is important that patients are seen by centers that regularly treat patients with mesothelioma.

Moreover, data have shown that surgical outcomes are better in patients with mesothelioma who receive care at high-volume centers vs low-volume centers. As such, patients should seek treatment at the best regional center near them, Zauderer concludes.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD